Global Intravitreal Injectable Market Growth 2021-2026

  • receipt Report ID : 251898
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 136
  • list Medical Devices

According to this latest study, the 2021 growth of Intravitreal Injectable will have significant change from previous year. By the most conservative estimates of global Intravitreal Injectable market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Intravitreal Injectable market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injectable market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Antimicrobials

Antibiotics

Antifungals

Antivirals

Anti-VEGF

Steroids

Cytokine Inhibitors

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospitals

Eye Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Regeneron Pharmaceuticals (Eylea)

iRenix

DelsiTech

Labtician Ophthalmics

Allegro Ophthalmics

RFE Pharma

GenSight Biologics

Allergan (Ozurdex)

EyePoint Pharmaceuticals

Genentech

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Intravitreal Injectable Consumption 2016-2026

2.1.2 Intravitreal Injectable Consumption CAGR by Region

2.2 Intravitreal Injectable Segment by Type

2.2.1 Antimicrobials

2.2.2 Antibiotics

2.2.3 Antifungals

2.2.4 Antivirals

2.2.5 Anti-VEGF

2.2.6 Steroids

2.2.7 Cytokine Inhibitors

2.3 Intravitreal Injectable Sales by Type

2.3.1 Global Intravitreal Injectable Sales Market Share by Type (2016-2021)

2.3.2 Global Intravitreal Injectable Revenue and Market Share by Type (2016-2021)

2.3.3 Global Intravitreal Injectable Sale Price by Type (2016-2021)

2.4 Intravitreal Injectable Segment by Application

2.4.1 Hospitals

2.4.2 Eye Clinics

2.4.3 Others

2.5 Intravitreal Injectable Sales by Application

2.5.1 Global Intravitreal Injectable Sale Market Share by Application (2016-2021)

2.5.2 Global Intravitreal Injectable Revenue and Market Share by Application (2016-2021)

2.5.3 Global Intravitreal Injectable Sale Price by Application (2016-2021)

3 Global Intravitreal Injectable by Company

3.1 Global Intravitreal Injectable Sales Market Share by Company

3.1.1 Global Intravitreal Injectable Sales by Company (2019-2021)

3.1.2 Global Intravitreal Injectable Sales Market Share by Company (2019-2021)

3.2 Global Intravitreal Injectable Revenue Market Share by Company

3.2.1 Global Intravitreal Injectable Revenue by Company (2019-2021)

3.2.2 Global Intravitreal Injectable Revenue Market Share by Company (2019-2021)

3.3 Global Intravitreal Injectable Sale Price by Company

3.4 Global Manufacturers Intravitreal Injectable Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Intravitreal Injectable Product Location Distribution

3.4.2 Players Intravitreal Injectable Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Intravitreal Injectable by Region

4.1 Global Intravitreal Injectable by Region

4.1.1 Global Intravitreal Injectable Sales by Region

4.1.2 Global Intravitreal Injectable Revenue by Region

4.2 Americas Intravitreal Injectable Sales Growth

4.3 APAC Intravitreal Injectable Sales Growth

4.4 Europe Intravitreal Injectable Sales Growth

4.5 Middle East & Africa Intravitreal Injectable Sales Growth

5 Americas

5.1 Americas Intravitreal Injectable Sales by Country

5.1.1 Americas Intravitreal Injectable Sales by Country (2016-2021)

5.1.2 Americas Intravitreal Injectable Revenue by Country (2016-2021)

5.2 Americas Intravitreal Injectable Sales by Type

5.3 Americas Intravitreal Injectable Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Intravitreal Injectable Sales by Region

6.1.1 APAC Intravitreal Injectable Sales by Region (2016-2021)

6.1.2 APAC Intravitreal Injectable Revenue by Region (2016-2021)

6.2 APAC Intravitreal Injectable Sales by Type

6.3 APAC Intravitreal Injectable Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Intravitreal Injectable by Country

7.1.1 Europe Intravitreal Injectable Sales by Country (2016-2021)

7.1.2 Europe Intravitreal Injectable Revenue by Country (2016-2021)

7.2 Europe Intravitreal Injectable Sales by Type

7.3 Europe Intravitreal Injectable Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Intravitreal Injectable by Country

8.1.1 Middle East & Africa Intravitreal Injectable Sales by Country (2016-2021)

8.1.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2021)

8.2 Middle East & Africa Intravitreal Injectable Sales by Type

8.3 Middle East & Africa Intravitreal Injectable Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Intravitreal Injectable Distributors

10.3 Intravitreal Injectable Customer

11 Global Intravitreal Injectable Market Forecast

11.1 Global Intravitreal Injectable Forecast by Region

11.1.1 Global Intravitreal Injectable Forecast by Regions (2021-2026)

11.2.2 Global Intravitreal Injectable Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Intravitreal Injectable Forecast by Type

11.7 Global Intravitreal Injectable Forecast by Application

12 Key Players Analysis

12.1 Regeneron Pharmaceuticals (Eylea)

12.1.1 Regeneron Pharmaceuticals (Eylea) Company Information

12.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered

12.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview

12.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments

12.2 iRenix

12.2.1 iRenix Company Information

12.2.2 iRenix Intravitreal Injectable Product Offered

12.2.3 iRenix Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 iRenix Main Business Overview

12.2.5 iRenix Latest Developments

12.3 DelsiTech

12.3.1 DelsiTech Company Information

12.3.2 DelsiTech Intravitreal Injectable Product Offered

12.3.3 DelsiTech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 DelsiTech Main Business Overview

12.3.5 DelsiTech Latest Developments

12.4 Labtician Ophthalmics

12.4.1 Labtician Ophthalmics Company Information

12.4.2 Labtician Ophthalmics Intravitreal Injectable Product Offered

12.4.3 Labtician Ophthalmics Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Labtician Ophthalmics Main Business Overview

12.4.5 Labtician Ophthalmics Latest Developments

12.5 Allegro Ophthalmics

12.5.1 Allegro Ophthalmics Company Information

12.5.2 Allegro Ophthalmics Intravitreal Injectable Product Offered

12.5.3 Allegro Ophthalmics Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Allegro Ophthalmics Main Business Overview

12.5.5 Allegro Ophthalmics Latest Developments

12.6 RFE Pharma

12.6.1 RFE Pharma Company Information

12.6.2 RFE Pharma Intravitreal Injectable Product Offered

12.6.3 RFE Pharma Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 RFE Pharma Main Business Overview

12.6.5 RFE Pharma Latest Developments

12.7 GenSight Biologics

12.7.1 GenSight Biologics Company Information

12.7.2 GenSight Biologics Intravitreal Injectable Product Offered

12.7.3 GenSight Biologics Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 GenSight Biologics Main Business Overview

12.7.5 GenSight Biologics Latest Developments

12.8 Allergan (Ozurdex)

12.8.1 Allergan (Ozurdex) Company Information

12.8.2 Allergan (Ozurdex) Intravitreal Injectable Product Offered

12.8.3 Allergan (Ozurdex) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Allergan (Ozurdex) Main Business Overview

12.8.5 Allergan (Ozurdex) Latest Developments

12.9 EyePoint Pharmaceuticals

12.9.1 EyePoint Pharmaceuticals Company Information

12.9.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Offered

12.9.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 EyePoint Pharmaceuticals Main Business Overview

12.9.5 EyePoint Pharmaceuticals Latest Developments

12.10 Genentech

12.10.1 Genentech Company Information

12.10.2 Genentech Intravitreal Injectable Product Offered

12.10.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Genentech Main Business Overview

12.10.5 Genentech Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Intravitreal Injectable Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Antimicrobials

Table 3. Major Players of Antibiotics

Table 4. Major Players of Antifungals

Table 5. Major Players of Antivirals

Table 6. Major Players of Anti-VEGF

Table 7. Major Players of Steroids

Table 8. Major Players of Cytokine Inhibitors

Table 9. Global Intravitreal Injectable Sales by Type (2016-2021) & (K Units)

Table 10. Global Intravitreal Injectable Sales Market Share by Type (2016-2021)

Table 11. Global Intravitreal Injectable Revenue by Type (2016-2021) & ($ million)

Table 12. Global Intravitreal Injectable Revenue Market Share by Type (2016-2021)

Table 13. Global Intravitreal Injectable Sale Price by Type (2016-2021)

Table 14. Global Intravitreal Injectable Sales by Application (2016-2021) & (K Units)

Table 15. Global Intravitreal Injectable Sales Market Share by Application (2016-2021)

Table 16. Global Intravitreal Injectable Value by Application (2016-2021)

Table 17. Global Intravitreal Injectable Revenue Market Share by Application (2016-2021)

Table 18. Global Intravitreal Injectable Sale Price by Application (2016-2021)

Table 19. Global Intravitreal Injectable Sales by Company (2019-2021) & (K Units)

Table 20. Global Intravitreal Injectable Sales Market Share by Company (2019-2021)

Table 21. Global Intravitreal Injectable Revenue by Company (2019-2021) ($ Millions)

Table 22. Global Intravitreal Injectable Revenue Market Share by Company (2019-2021)

Table 23. Global Intravitreal Injectable Sale Price by Company (2019-2021)

Table 24. Key Manufacturers Intravitreal Injectable Producing Area Distribution and Sales Area

Table 25. Players Intravitreal Injectable Products Offered

Table 26. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Intravitreal Injectable Sales by Region (2016-2021) (K Units)

Table 30. Global Intravitreal Injectable Sales Market Share by Region (2016-2021)

Table 31. Global Intravitreal Injectable Revenue by Region (2016-2021) & ($ Millions)

Table 32. Global Intravitreal Injectable Revenue Market Share by Region (2016-2021)

Table 33. Americas Intravitreal Injectable Sales by Country (2016-2021) & (K Units)

Table 34. Americas Intravitreal Injectable Sales Market Share by Country (2016-2021)

Table 35. Americas Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)

Table 36. Americas Intravitreal Injectable Revenue Market Share by Country (2016-2021)

Table 37. Americas Intravitreal Injectable Sales by Type (2016-2021) & (K Units)

Table 38. Americas Intravitreal Injectable Sales Market Share by Type (2016-2021)

Table 39. Americas Intravitreal Injectable Sales by Application (2016-2021) & (K Units)

Table 40. Americas Intravitreal Injectable Sales Market Share by Application (2016-2021)

Table 41. APAC Intravitreal Injectable Sales by Region (2016-2021) & (K Units)

Table 42. APAC Intravitreal Injectable Sales Market Share by Region (2016-2021)

Table 43. APAC Intravitreal Injectable Revenue by Region (2016-2021) & ($ Millions)

Table 44. APAC Intravitreal Injectable Revenue Market Share by Region (2016-2021)

Table 45. APAC Intravitreal Injectable Sales by Type (2016-2021) & (K Units)

Table 46. APAC Intravitreal Injectable Sales Market Share by Type (2016-2021)

Table 47. APAC Intravitreal Injectable Sales by Application (2016-2021) & (K Units)

Table 48. APAC Intravitreal Injectable Sales Market Share by Application (2016-2021)

Table 49. Europe Intravitreal Injectable Sales by Country (2016-2021) & (K Units)

Table 50. Europe Intravitreal Injectable Sales Market Share by Country (2016-2021)

Table 51. Europe Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)

Table 52. Europe Intravitreal Injectable Revenue Market Share by Country (2016-2021)

Table 53. Europe Intravitreal Injectable Sales by Type (2016-2021) & (K Units)

Table 54. Europe Intravitreal Injectable Sales Market Share by Type (2016-2021)

Table 55. Europe Intravitreal Injectable Sales by Application (2016-2021) & (K Units)

Table 56. Europe Intravitreal Injectable Sales Market Share by Application (2016-2021)

Table 57. Middle East & Africa Intravitreal Injectable Sales by Country (2016-2021) & (K Units)

Table 58. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2016-2021)

Table 59. Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)

Table 60. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2016-2021)

Table 61. Middle East & Africa Intravitreal Injectable Sales by Type (2016-2021) & (K Units)

Table 62. Middle East & Africa Intravitreal Injectable Sales Market Share by Type (2016-2021)

Table 63. Middle East & Africa Intravitreal Injectable Sales by Application (2016-2021) & (K Units)

Table 64. Middle East & Africa Intravitreal Injectable Sales Market Share by Application (2016-2021)

Table 65. Key and Potential Regions of Intravitreal Injectable

Table 66. Key Application and Potential Industries of Intravitreal Injectable

Table 67. Key Challenges of Intravitreal Injectable

Table 68. Key Trends of Intravitreal Injectable

Table 69. Intravitreal Injectable Distributors List

Table 70. Intravitreal Injectable Customer List

Table 71. Global Intravitreal Injectable Sales Forecast by Region (2021-2026) & (K Units)

Table 72. Global Intravitreal Injectable Consumption Market Forecast by Region

Table 73. Global Intravitreal Injectable Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2021-2026)

Table 75. Americas Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Americas Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. APAC Intravitreal Injectable Sales Forecast by Region (2021-2026) & (K Units)

Table 78. APAC Intravitreal Injectable Revenue Forecast by Region (2021-2026) & ($ millions)

Table 79. Europe Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)

Table 80. Europe Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)

Table 81. Middle East & Africa Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)

Table 82. Middle East & Africa Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)

Table 83. Global Intravitreal Injectable Sales Forecast by Type (2021-2026) & (K Units)

Table 84. Global Intravitreal Injectable Sales Market Share Forecast by Type (2021-2026)

Table 85. Global Intravitreal Injectable Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 86. Global Intravitreal Injectable Revenue Market Share Forecast by Type (2021-2026)

Table 87. Global Intravitreal Injectable Sales Forecast by Application (2021-2026) & (K Units)

Table 88. Global Intravitreal Injectable Sales Market Share Forecast by Application (2021-2026)

Table 89. Global Intravitreal Injectable Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 90. Global Intravitreal Injectable Revenue Market Share Forecast by Application (2021-2026)

Table 91. Regeneron Pharmaceuticals (Eylea) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 92. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered

Table 93. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Regeneron Pharmaceuticals (Eylea) Main Business

Table 95. Regeneron Pharmaceuticals (Eylea) Latest Developments

Table 96. iRenix Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 97. iRenix Intravitreal Injectable Product Offered

Table 98. iRenix Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. iRenix Main Business

Table 100. iRenix Latest Developments

Table 101. DelsiTech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 102. DelsiTech Intravitreal Injectable Product Offered

Table 103. DelsiTech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. DelsiTech Main Business

Table 105. DelsiTech Latest Developments

Table 106. Labtician Ophthalmics Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 107. Labtician Ophthalmics Intravitreal Injectable Product Offered

Table 108. Labtician Ophthalmics Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Labtician Ophthalmics Main Business

Table 110. Labtician Ophthalmics Latest Developments

Table 111. Allegro Ophthalmics Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 112. Allegro Ophthalmics Intravitreal Injectable Product Offered

Table 113. Allegro Ophthalmics Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Allegro Ophthalmics Main Business

Table 115. Allegro Ophthalmics Latest Developments

Table 116. RFE Pharma Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 117. RFE Pharma Intravitreal Injectable Product Offered

Table 118. RFE Pharma Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. RFE Pharma Main Business

Table 120. RFE Pharma Latest Developments

Table 121. GenSight Biologics Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 122. GenSight Biologics Intravitreal Injectable Product Offered

Table 123. GenSight Biologics Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. GenSight Biologics Main Business

Table 125. GenSight Biologics Latest Developments

Table 126. Allergan (Ozurdex) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 127. Allergan (Ozurdex) Intravitreal Injectable Product Offered

Table 128. Allergan (Ozurdex) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. Allergan (Ozurdex) Main Business

Table 130. Allergan (Ozurdex) Latest Developments

Table 131. EyePoint Pharmaceuticals Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 132. EyePoint Pharmaceuticals Intravitreal Injectable Product Offered

Table 133. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. EyePoint Pharmaceuticals Main Business

Table 135. EyePoint Pharmaceuticals Latest Developments

Table 136. Genentech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors

Table 137. Genentech Intravitreal Injectable Product Offered

Table 138. Genentech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. Genentech Main Business

Table 140. Genentech Latest Developments

List of Figures

Figure 1. Picture of Intravitreal Injectable

Figure 2. Intravitreal Injectable Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Intravitreal Injectable Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Intravitreal Injectable Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Intravitreal Injectable Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Antimicrobials

Figure 10. Product Picture of Antibiotics

Figure 11. Product Picture of Antifungals

Figure 12. Product Picture of Antivirals

Figure 13. Product Picture of Anti-VEGF

Figure 14. Product Picture of Steroids

Figure 15. Product Picture of Cytokine Inhibitors

Figure 16. Global Intravitreal Injectable Sales Market Share by Type in 2020

Figure 17. Global Intravitreal Injectable Revenue Market Share by Type (2016-2021)

Figure 18. Intravitreal Injectable Consumed in Hospitals

Figure 19. Global Intravitreal Injectable Market: Hospitals (2016-2021) & (K Units)

Figure 20. Intravitreal Injectable Consumed in Eye Clinics

Figure 21. Global Intravitreal Injectable Market: Eye Clinics (2016-2021) & (K Units)

Figure 22. Intravitreal Injectable Consumed in Others

Figure 23. Global Intravitreal Injectable Market: Others (2016-2021) & (K Units)

Figure 24. Global Intravitreal Injectable Sales Market Share by Application (2016-2021)

Figure 25. Global Intravitreal Injectable Revenue Market Share by Application in 2020

Figure 26. Intravitreal Injectable Revenue Market by Company in 2020 ($ Million)

Figure 27. Global Intravitreal Injectable Revenue Market Share by Company in 2020

Figure 28. Global Intravitreal Injectable Sales Market Share by Regions (2016-2021)

Figure 29. Global Intravitreal Injectable Revenue Market Share by Region in 2020

Figure 30. Americas Intravitreal Injectable Sales 2016-2021 (K Units)

Figure 31. Americas Intravitreal Injectable Revenue 2016-2021 ($ Millions)

Figure 32. APAC Intravitreal Injectable Sales 2016-2021 (K Units)

Figure 33. APAC Intravitreal Injectable Revenue 2016-2021 ($ Millions)

Figure 34. Europe Intravitreal Injectable Sales 2016-2021 (K Units)

Figure 35. Europe Intravitreal Injectable Revenue 2016-2021 ($ Millions)

Figure 36. Middle East & Africa Intravitreal Injectable Sales 2016-2021 (K Units)

Figure 37. Middle East & Africa Intravitreal Injectable Revenue 2016-2021 ($ Millions)

Figure 38. Americas Intravitreal Injectable Sales Market Share by Country in 2020

Figure 39. Americas Intravitreal Injectable Revenue Market Share by Country in 2020

Figure 40. Americas Intravitreal Injectable Sales Market Share by Type in 2020

Figure 41. Americas Intravitreal Injectable Sales Market Share by Application in 2020

Figure 42. United States Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 43. Canada Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 44. Mexico Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 45. Brazil Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 46. APAC Intravitreal Injectable Sales Market Share by Region in 2020

Figure 47. APAC Intravitreal Injectable Revenue Market Share by Regions in 2020

Figure 48. APAC Intravitreal Injectable Sales Market Share by Type in 2020

Figure 49. APAC Intravitreal Injectable Sales Market Share by Application in 2020

Figure 50. China Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 51. Japan Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 52. Korea Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 53. Southeast Asia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 54. India Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 55. Australia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 56. Europe Intravitreal Injectable Sales Market Share by Country in 2020

Figure 57. Europe Intravitreal Injectable Revenue Market Share by Country in 2020

Figure 58. Europe Intravitreal Injectable Sales Market Share by Type in 2020

Figure 59. Europe Intravitreal Injectable Sales Market Share by Application in 2020

Figure 60. Germany Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 61. France Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 62. UK Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 63. Italy Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 64. Russia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 65. Middle East & Africa Intravitreal Injectable Sales Market Share by Country in 2020

Figure 66. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country in 2020

Figure 67. Middle East & Africa Intravitreal Injectable Sales Market Share by Type in 2020

Figure 68. Middle East & Africa Intravitreal Injectable Sales Market Share by Application in 2020

Figure 69. Egypt Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 70. South Africa Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 71. Israel Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 72. Turkey Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 73. GCC Country Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

Please fill the form below, to recieve the report sample


+1